Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects With Erythematous Rosacea

NCT01186068 is registered in ClinicalTrials.gov with Vicept Therapeutics, Inc. as lead sponsor.

NCT NCT01186068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01186068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects With Erythematous Rosacea
Lead sponsor
Vicept Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
Not reported
Enrollment
175 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

erythematous (type one) rosacea